Document is current
Any future updates will be listed below
-
Authors
Soltani, Soheil
Paulson, Jack G.
Fong, Emma J.
Mumenthaler, Shannon M.
Armani, Andrea M.
-
Funding
Funding for this research was provided by:
National Cancer Institute Cancer Systems Biology Consortium (U01CA232137)
Office of Naval Research (N00014-24-1-2296)
National Science Foundation (DBI-2414158)
- License Information
-
More Information
Article History
Received: 16 July 2025
Accepted: 10 October 2025
First Online: 17 November 2025
Declarations
:
: Shannon M. Mumenthaler is the Chief Translational Research Officer for the Ellison Medical Institute. Andrea M. Armani is the Senior Director, Physical Sciences and Engineering at the Ellison Medical Institute. Emma Fong is a Research Scientist at the Ellison Medical Institute. Soheil Soltani is a Research Scientist at the Ellison Medical Institute. The other authors declare no competing interests.
: The use of patient samples was reviewed and approved by the University of Southern California Biomedical Institutional Review Board, under protocol number HS-06–00678. All patients provided written informed consent prior to sample collection. Samples were de-identified to research staff.
: Experimental protocol approval: All the experimental protocols were carried out in accordance with Institutional Review Board (Protocol HS-06-00678) approval. Method approval: All methods were carried out in accordance with the guidelines and regulations set in the Ellison Medical Institute Umbrella Biohazardous Use Authorization approved by the Institutional Biosafety Committee.
